Nike's 407% Profit Jump Came From a Courtroom, Not a Shoebox

Nike's fiscal fourth-quarter net income rose 407% - from $211 million a year ago to $1.07 billion. Almost none of that improvement came from selling shoes. On February 20, 2026, the U.S. Supreme Court ruled that tariffs imposed under the International Emergency Economic Powers Act (IEEPA) were unauthorized, and in Q4 Nike deemed recovery of the tariffs it had paid to be probable. The result: a one-time $986 million benefit booked in cost of sales, worth roughly 900 basis points of Q4 gross margin and $0.52 of the quarter's $0.72 in diluted EPS. Strip it out and Nike earned $0.20 a share - on revenue that declined 1%.

That accounting quirk is the perfect frame for the real question in Nike's FY2026 10-K (filed July 15, 2026): after a two-year, $5 billion revenue reset, is the floor finally in - or is a headline profit number masking demand that is still eroding? The stock has already voted once: at roughly $44, NKE is down about 41% over the past year and trades near the bottom of its 52-week range of $40.00 to $80.17.

Company Snapshot

NIKE, Inc. (NYSE: NKE) is the world's largest seller of athletic footwear and apparel, selling through wholesale partners and its own NIKE Direct stores and digital platforms across four geographies - North America, EMEA, Greater China, and Asia Pacific and Latin America - plus the Jordan Brand (reported inside the geographic segments) and the stand-alone Converse subsidiary. This is initiating RoboSystems coverage, built on the FY2026 10-K covering the year ended May 31, 2026 - CEO Elliott Hill's first full fiscal year running his "Win Now" turnaround and new "Sport Offense" operating model.

The Financial Story

The top line has stopped falling - and stopped there. FY2026 revenue was $46.40 billion, essentially flat against FY2025's $46.31 billion but down 2% on a currency-neutral basis, and roughly 10% below the FY2024 peak of $51.36 billion. The five-year tape tells the story of a full round trip: $46.7 billion in FY2022, $51.2 billion in FY2023, $51.4 billion in FY2024, then the reset to $46.3 billion and $46.4 billion. Management guided the next six months down again - low-to-mid single digits - so the "flat" year is not yet a recovery year. Notably, this reset was partly deliberate: Nike says it pulled more than $2 billion of classic franchises (Air Force 1, Dunk-era lifestyle product) out of the market in FY2026 to drain over-distributed inventory.

The margin story splits in two. Reported full-year gross margin was 42.9%, up 20 basis points - but that includes a 210 basis point lift from the tariff recovery. Excluding it, underlying gross margin was 40.8%, down nearly two points, and full-year EPS of $2.10 becomes $1.58. The Q4 version is starker: 49.2% reported versus 40.2% underlying, down 10 basis points year over year. The honest read is that margins have stopped compressing - Q4's underlying decline of 10 basis points beat management's own guide of down 25 to 75 - but the recovery hasn't started showing up in the reported base yet. Meanwhile Nike absorbed $385 million of severance charges in FY2026 as it cut supply-chain and technology overhead, and management says gross margin should inflect positive in Q1 FY2027.

Under the surface, two different companies are moving in opposite directions. Performance product grew mid-single digits: NIKE Running has posted five straight quarters of double-digit growth, adding roughly $1 billion of revenue and 5 points of running market share in statement footwear across North America and Western Europe. Wholesale grew 6% reported to $27.5 billion, and Nike's revenue with Foot Locker comped positive for the first time in four years. But NIKE Direct fell 6% to $17.7 billion, with digital down 12% - partly a deliberate pullback on promotions to rebuild full-price selling, partly soft traffic. And the lifestyle side - NIKE Sportswear and Jordan streetwear, roughly half of revenue - remains in decline, with Jordan Brand down 3% to $7.0 billion. Management expects both to stay negative into the back half of FY2027. Geographically, North America carried the year (up 5% to $20.5 billion, with EBIT up 14%), while Greater China fell 11% to $5.8 billion with EBIT down 20%, and Converse collapsed 31% to $1.2 billion with segment EBIT down 93% to just $18 million. The 10-K states plainly that Greater China and Converse headwinds will persist throughout fiscal 2027.

The balance sheet is solid but the cash math got tight. Cash and short-term investments of $9.0 billion sit against $7.9 billion of debt - about $1.1 billion of net cash - though $2.0 billion of that debt is now current. Inventories held flat at $7.5 billion, a genuine discipline signal given falling sales, while accounts receivable jumped 26% to $5.9 billion - mostly the $684 million tariff receivable, which Nike says was substantially collected after year-end. The sharper signal: operating cash flow fell 22% to $2.87 billion, and free cash flow of roughly $2.2 billion (after $684 million of capex) no longer covers the $2.4 billion dividend. Nike all but suspended buybacks - $123 million in FY2026 versus $2.99 billion the year before. A company that returned $2.5 billion to shareholders while generating $2.2 billion of free cash is spending down flexibility to defend its dividend streak until earnings recover.

Valuation - What It's Worth as a Normal Business

Where it trades: at $44.19 (intraday July 16, 2026), Nike's market cap is about $65.5 billion, with an enterprise value near $64.4 billion. That's 21.0 times reported trailing EPS - but 28 times the $1.58 underlying EPS once the tariff windfall is stripped out, and 24.9 times forward consensus. EV to EBITDA is about 14.4 times, price to sales 1.41 times, and the $1.64 dividend now yields 3.7% - a level Nike shareholders have never been paid before, because the stock has never been this cheap relative to its payout. Free cash flow yield is roughly 3.3%. Analyst consensus (39 analysts) averages a $51.30 price target with a Buy-to-Hold split and a huge dispersion - from BTIG at $55 down to BNP Paribas at $23 - which is itself evidence that this is a battleground stock. Peers frame the debate: Lululemon has de-rated to 9.5 times trailing earnings, Deckers to 15.2 times, while On Holding still commands about 20.8 times forward. Nike is priced at a premium to nearly all of them on earnings that are currently depressed.

Scenario DCF, with assumptions stated. Using FY2026 as the base year (underlying EBIT of roughly $2.9 billion, a 6.2% margin), a ten-year cash-flow model with a 21% tax rate and about 95% of after-tax operating profit converting to free cash flow: the bear case (revenue declines continue through FY2028, EBIT margin stuck near 7.5%, 9.5% discount rate, 1.5% terminal growth) is worth about $20 per share. The base case (revenue down 3% in FY2027 then recovering to 3-4% growth, EBIT margin rebuilding to 11% by FY2032, 9% discount rate, 2.5% terminal growth) is worth about $38. The bull case (growth returns in FY2028 and margins recover to 12.5% - near pre-reset levels - 8.5% discount rate, 3% terminal growth) is worth about $59. A peer re-rating check points the same direction: if earnings normalize to $2.75-$3.25 of EPS by FY2029 and the stock commands a 16-to-20 times multiple (between Deckers today and Nike's own history), implied value is roughly $44 to $66.

Read those ranges against the $44 price and the message is uncomfortable for both bulls and bears: today's price is above the base-case DCF and sits at the very bottom of the re-rating range. In other words, the market is already paying 28 times trough earnings - pricing in a meaningful margin recovery that hasn't yet appeared in a single reported quarter. The upside case from here isn't that a recovery happens; it's that the recovery is faster and bigger than the roughly 11%-margin path already embedded. These are implied values under stated assumptions - not price targets, and not investment advice.

Risks

The filing's own risk factors do a lot of work here. Tariffs remain a live cost: the Supreme Court refund covers what was already paid, but Nike's forward guidance assumes new incremental tariff rates of 10% through July, rising to 15% thereafter - a structural cost the refund does nothing to fix. Consumer softness is explicit: management saw retail sales decelerate from mid-April, calls out pressure on traffic and discretionary spending across geographies, and is guiding revenue down low-to-mid single digits for the next six months, with Q2 facing a multipoint headwind from prior-year comparisons. Greater China (down 13% currency-neutral, with the 10-K flagging declining store traffic, elevated promotions, and excess marketplace inventory) and Converse (down 31%) are both expected to stay negative throughout FY2027. Half the company - Sportswear and Jordan streetwear - is still shrinking, and EMEA inventory is up low double digits. Add execution risk at the top: CFO Matthew Friend departs after nearly 18 years, with Pfizer's David Denton taking over August 17 - a proven operator, but one with no activewear experience, and history says new CFOs like to reset guidance low. Finally, the dividend now exceeds free cash flow; if the earnings recovery slips a year, that math forces harder choices.

The Bottom Line

FY2026 looks like the engineered trough of the turnaround: revenue flat by design, underlying margins stabilizing, inventory clean, performance product genuinely working - and a one-time $986 million courtroom windfall making the headline numbers look better than the business actually performed. The stock at $44 is neither obviously cheap (28 times underlying earnings, dividend uncovered by free cash flow) nor obviously expensive (roughly 1.4 times sales for the world's dominant sportswear franchise, with $9 billion of liquidity). The watch items are concrete: whether gross margin ex-one-timer actually inflects positive in Q1 FY2027 as guided, whether Sportswear's dozen new footwear styles stop the lifestyle bleed in the back half, whether Greater China stabilizes, and what the new CFO and the November 16-17 Investor Day do to the FY2028 margin path. The floor is probably in for the business. Whether it's in for the stock depends on a recovery the market has already partially paid for.

This analysis was built from NIKE's FY2026 10-K via the RoboSystems structured SEC filing repository - every number queryable at the source. Try it at robosystems.ai. New customers get 50% off your first month with code ROBO50.